A Phase 4 Randomized Double-blind Placebo-Controlled Study of Rimegepant for Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
Messoud Ashina, Peter McAllister, Luz M Ramirez, Catherine Nalpas,
Alexandra Thiry, Lucy Abraham, Robert Fountaine, Terence Fullerton
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Burden of Self-Reported Migraine in the Pfizer Ireland Workforce –a Cross-Sectional Study
Dooley, Garreth, Nakajima, Karina; Patten, Sarah; Chern Chuan, Soo; Feng, Dai; Turko, Alexis
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Consistency of Response to Rimegepant for the Acute Treatment of Migraine: A Population and Participant-Level Analysis of a Prospective Real-World Observational Study (CONFIDENCE)
Lucy Abraham, Alexandre Urani, Giorgio Lambru, Richard B Lipton, Peter J Goadsby, Patricia Pozo-Rosich, Kristina M Fanning, Feng Dai, Karin Hygge Blakeman
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Does heterogeneity in patient population, study design, and endpoint definitions affect indirect comparisons of acute migraine treatments? A methodological assessment
Richard B Lipton,Phoebe Cowley,Emma Benbow,Tim Reason,Anthony J Hatswell,Aaron Jenkins,Lucy Abraham,Phillip Saccone,Haitao Chu,Terry Fullerton,andCristina Tassorelli
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Evaluation of real-world effectiveness of acute migraine treatment: results from DREAM, a nationwide population study on 58,000 people
Henrik Winther Schytz,Daniel S Hauberg, Ulla S Lønberg, Aaron Jenkins, Lucy Abraham, Karin Hygge Blakeman, Maria Spanggaard, Jens Olsen, Christine Bach, Thomas F Hansen
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Migraine related sick leave among people with effective treatment of migraine: results from DREAM, a nationwide population study
Henrik Winther Schytz,Daniel S Hauberg,Ulla S Lønberg, Aaron Jenkins, Lucy Abraham, Karin Hygge Blakeman, Maria Spanggaard, Jens Olsen, Christine Bach, Thomas F Hansen
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Patient experiences and preferences for non-oral acute migraine treatments: A discrete choice experiment
Lena Hubig, Timothy Smith, Lucy Abraham, Josh Coulter, Karin
Hygge Blakeman, Joseph C Cappelleri, Ekta Agarwal, Siu Hing Lo
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Prospective, Real-World Evidence of Meaningful Pain Relief, Return to Function, and Satisfaction Among Patients With Migraine on Acute Rimegepant Treatment Alone or With Concomitant Preventive Migraine Medication
Karin Hygge Blakema1, Alexandre Urani, Giorgio Lambru, Richard B Lipton,
Peter J Goadsby, Patricia Pozo-Rosich, Todd J Schwedt, Kristina M Fanning,
Lucy Abraham
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Reasons for Discontinuing Triptans Among Current Users of Rimegepant for the Acute Treatment of Migraine in the CONFIDENCE Study
Karin Hygge Blakeman, Alexandre Urani, Giorgio Lambru, Richard B Lipton,
Peter J Goadsby, Patricia Pozo-Rosich, Todd J Schwedt, Kristina M Fanning,
Feng Dai, Lucy Abraham
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Safety and Effectiveness of Rimegepant for Acute Treatment of Migraine in Adults Unsuitable for Triptan Use: Results From a 12-week Open-Label Extension Phase
Messoud Ashina, Peter McAllister, Charly Gaul, Adolfo Leyva-Rendon,
Luz M Ramirez, Catherine Nalpas, Alexandra Thiry, Lucy Abraham,
Robert Fountaine, Terence Fullerton
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
